Renata Yokota, PhD

P95, Leuven, Belgium, Belgium

Disclosure(s): P95 Epidemiology & Pharmacovigilance/AstraZeneca: Employee of P95 Epidemiology & Pharmacovigilance, which received a consultancy fee for the conduct of the current study from AstraZeneca

Poster(s):

• (P-1989) COVID-19 Mortality Among Immunocompromised Individuals is Consistently High Compared with Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-2006) Individuals on Immunosuppressive or Immunomodulatory Therapies Remain at Increased Risk of COVID-19 Hospitalization, Despite Vaccination: Findings from INFORM, a Retrospective Health Database Study in England
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT